Home > Boards > Free Zone > User's Groups > $$$$$$$$ MICK, $Pistol Pete$ PINCHER CHART PLAYS $$$$$$$$

$BNGO Associate Director of R&D of diagnostic company

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
SpotOnTrade Member Profile
Member Level 
Followed By 752
Posts 120,783
Boards Moderated 4
Alias Born 08/13/10
160x600 placeholder
Stock Futures Rise Ahead of Stimulus Talks Deadline
U.S. stock futures ticked up ahead of House Speaker Nancy Pelosi's Tuesday deadline for Congress to reach an agreement on a spending package to support American households and businesses through the pandemic.
UBS Nearly Doubles Profit on Strong Investment Bank, Wealth Management Units -- Earnings Review
Airbus and Israel Partner Win Maritime Aerial Surveillance Contract
UBS Profit Doubles on Trading Surge -- 2nd Update
Britvic Sees Fiscal Year 2020 Adjusted Profit Above Market Views; Cautions on Fiscal Year 2021 -- Update
Siemens Healthineers Plans to Invest EUR160 Million in India Innovation Hub
Sweden Bans Use of Huawei and ZTE Products in Critical 5G Infrastructure
Top Company News of the Day
Reckitt Benckiser Disinfectant Brands Drove 3Q Revenue Growth During Pandemic -- Update
Alibaba Takes 6.1% Stake in Travel Retailer Dufry
Britvic Sees Fiscal Year 2020 Adjusted Profit Above Market Views; Cautions on Fiscal Year 2021
AstraZeneca Granted US Priority Review for Early-Stage Lung Cancer Adjuvant Drug
Reckitt Benckiser's Disinfection Brands Drove 3Q Revenue Growth Amid Pandemic
Total Delivers its First Carbon Neutral LNG Cargo
UBS Profit Doubles on Trading Surge -- Update
Swedbank 3Q Net Profit Beat Views on Higher Income, Lower Costs
UBS Sets Aside Reserve for Buybacks After Strong 3Q -- Update
BMW 3Q Auto Segment Cash Flow Exceeded Expectations
UBS Sets Aside Reserve for Buybacks After Strong 3Q
UBS Publishes Agenda for Extraordinary General Meeting on 19 November 2020
Foxconn's Terry Gou Says Big Wisconsin Project Hinges on State Aid
3Q20 Net Profit USD 2.1bn, 21.9% Return on CET1 Capital
Ant Group Nears Giant IPO After Green Light From Hong Kong's Exchange
Moderna CEO Expects Covid-19 Vaccine Interim Results in November
SpotOnTrade Member Level  Tuesday, 10/29/19 02:17:43 PM
Re: seventhcircle post# 589
Post # of 640 
$BNGO Associate Director of R&D of diagnostic company GeneDx presented a Saphyr validation study for the detection of the disease-causing variants in FSHD and repeat expansion disorders such as Mytonic Dystrophy 1 and 2. For the 40 samples genotyped for the contraction causing FSHD and the 36 samples genotyped for CNBP gene expansion that causes Mytonic Dystrophy 2, the results generated with Saphyr had a sensitivity, specificity and Positive Predictive Value of 100%. http://www.globenewswire.com/news-release/2019/10/24/1934941/0/en/Takeaways-from-ASHG-2019-in-Houston-Users-of-Bionano-s-Saphyr-System-Presented-Validation-Results-for-FSHD-Repeat-Expansion-Disorders-and-Digital-Cytogenetics-Among-a-Growing-List-.html

Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences